Outpatient Therapeutics Mini-Series

This mini-series, supported by HHS ASPR, will provide a deep dive on new and emerging COVID-19 outpatient therapeutics, including monoclonal antibodies. The goal of this mini-series is to equip clinicians with the appropriate knowledge, resources, and tools needed to initiate and scale administration of these therapies and reduce strain on the U.S. healthcare system.

Contact c19echo@salud.unm.edu for more information

Register for this Series 

Dates: Wednesdays, 12:00-1:00 p.m. ET starting December 9.

 

Past Session Material

January 6, 2021

  • Monoclonal Antibody Therapy in Michigan: A Preliminary Analysis of the First 1500 Patients-William Fales, MD, FACEP (State Medical Director, Division of EMS and Trauma, Michigan Department of Health and Human Services; Lansing, MI)
  • COVID-19 Vaccine Roll-Out in Nursing Homes: Where do Monoclonal Antibodies Fit in? Swati Gaur, MD (Geriatrician/Medical Director and Chair of Infections Advisory Committee with AMDA -The Society for Post-Acute and Long-Term Care Medicine; Gainesville, GA)
  • Video Link